← Back to Clinical Trials
Recruiting NCT07248709

NCT07248709 Comparison of High-Intensity Interval Training and Moderate-Intensity Continuous Training in Mild Cognitive Impairment

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07248709
Status Recruiting
Phase
Sponsor Riphah International University
Condition Mild Cognitive Impairment
Study Type INTERVENTIONAL
Enrollment 68 participants
Start Date 2025-11-05
Primary Completion 2026-04-12

Trial Parameters

Condition Mild Cognitive Impairment
Sponsor Riphah International University
Study Type INTERVENTIONAL
Phase N/A
Enrollment 68
Sex ALL
Min Age 60 Years
Max Age N/A
Start Date 2025-11-05
Completion 2026-04-12
Interventions
High-Intensity Interval Training (HIIT)Moderate-Intensity Continuous Training

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This study aims to determine the effects of High-Intensity Interval Training (HIIT) and Moderate-Intensity Continuous Training (MICT) on cognitive and physical fitness in community-dwelling adults diagnosed with Mild Cognitive Impairment (MCI). A double-blinded randomized clinical trial will be conducted for ten months at Ruhama Welfare Foundation Society Lahore and Kainat Patient Care and Old Age Home, Lahore. The sample size is calculated through G-power and 68 participants will be recruited through the non-probability convenience sampling technique. Those who meet the inclusion criteria will be randomized into two groups through the online randomizer tool. Both experimental groups will undergo an 8-week intervention, consisting of three sessions per week with alternate-day training of 38 minutes. The HIIT group will perform exercise with each session consisting of four 4-minute intervals at 85-95% of their maximum heart rate, with 3-minute active recovery periods, while the MICT group will engage in continuous exercise for 28 minutes at 70-75% of their maximum heart rate. Assessment will be done at baseline, after the 4th week, 8th week, and follow-up at 12th week.

Eligibility Criteria

Inclusion Criteria: * older adults who had been diagnosed with MCI according to Peterson's criteria \[Montreal Cognitive Assessment (MoCA) score \<26 for those with 12 years or more of education and \<25 for those with less than 12 years of education; activity of daily living scale ≤23; no clinical diagnosis of dementia\] * older adults who are physically normal (the six-item Katz Activities of Daily Living Scale should all be evaluated as "independent") Exclusion Criteria: * Participants who have medical problems or co-morbidities that interdict their participation in the study. * Unable to walk without an assistive device * Diagnosed with neurodegenerative diseases such as Alzheimer's disease * Having regular exercise habits (defined as exercise for ≥150 min per week). * Participating in other ongoing intervention study

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology